Amgen, Inc. (NASDAQ:AMGN) plunged -1.01% during previous trade, a total of 2.91M shares exchanged hands compared with its average trading volume of 4.08M shares whereas its relative volume is 0.77. The stock has a market capitalization of $116.86B along with 735.89M outstanding shares. Stock’s intraday price range hit the peak level of $162.73 and touched the lowest level of $160.25.
Most recently Amgen, Inc. (NASDAQ:AMGN)’s price target was revised on 4/17/17 and according to 20 analysts stock’s price will reach at $185.13 during 52 weeks with standard deviation of 14.68. Stock’s minimum price target estimates has been figured out at $158.51 while the maximum price target forecast is established at $212, if we look at the price target with an optimistic approach it has upside potential of 32% from its latest closing price of $160.41.
Historically, if we look at price target revisions, two week ago Amgen, Inc. (NASDAQ:AMGN)’s price target was revised on 4/05/17 by the analysts, however the bullish price estimates of the stock set at $209 while the bearish estimates kept at $161 over the next one year. Stock’s 52-week target was retained at $182.64, the estimates indicates a standard deviation of 14.84.
While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.37. ABR value is precisely based on brokerage recommendations, where out of 15 brokerage recommendations 4 rate Amgen, Inc. (NASDAQ:AMGN) stock a Strong Buy, 1 rate the stocks of the company a Buy, 10 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 4/5/17 the stock of Amgen, Inc. (NASDAQ:AMGN) downgraded by Jefferies from Buy to Hold. However previously on 2/1/17 it was upgraded by BofA/Merrill from Neutral to Buy. A research note issued on 12/20/16 the stock was downgraded Credit Suisse from Outperform to Neutral.
Amgen, Inc. (NASDAQ:AMGN) performance over the past one year soared 0.17% whereas its year to date (YTD) performance indicated a bullish trend of 10.47%. During the last six months the stock climbed 0.95%. Quarterly performance of the company shows optimistic momentum of 4.43% while its last one month trend is negative with -4.20%. Stock’s weekly performance expressed down trend of -0.74%.
The company’s price sits -5.57% below from its 50-day moving average of $168.51 and -0.11% away from the stock’s 200-day moving average which is $158.62. Baidu Amgen, Inc. (NASDAQ:AMGN)’s shares are currently trading -12.92% away from the 52-week high price of $184.21 and +21.68% far from the 52-week low price of $131.83.
According to consensus agreement of 21 analysts Amgen, Inc. (NASDAQ:AMGN) will report earnings per share of $3 in their quarterly report and it is expected to announce the company’s results on 4/26/17 After Market Close. For the current quarter the company has high EPS estimates of $3.19 in contradiction of low EPS estimates of $2.8. However a year ago for the same quarter the company has reported $2.9 EPS. Current year EPS projections for Amgen, Inc. (NASDAQ:AMGN) set at $12.33 according to the sentiments of 24 analysts, while its lowest earnings estimates are $11.84 and highest earnings estimates are $12.94.
According to 18 analysts, Amgen, Inc. (NASDAQ:AMGN)’s revenue estimates for the current quarter are $5.61B meanwhile the company has high revenue estimates of $5.82B in contradiction of low revenue estimates of $5.33B. For the current year the company’s revenue estimates are $23.04B compared to low analyst estimates of $22.47B and high estimates of $23.6B according to the projection of 22 analysts.